Anzahl der Publikationen: 7
Zeitschriftenartikel
Pozios, Ioannis; Seel, Nina N.; Hering, Nina A.; Hartmann, Lisa; Liu, Verena; Camaj, Peter; Müller, Mario H.; Lee, Lucas D.; Bruns, Christiane J.; Kreis, Martin E. und Seeliger, Hendrik
(2020):
Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ER beta and IL-6/gp130/STAT3 signaling.
In: Cellular Oncology, Bd. 44, Nr. 1: S. 167-177
Pozios, Ioannis; Knoesel, Thomas; Zhao, Yue; Assmann, Gerald; Pozios, Iraklis; Müller, Mario H.; Bruns, Christiane J.; Kreis, Martin E. und Seeliger, Hendrik
(2018):
Expression of phosphorylated estrogen receptor beta is an independent negative prognostic factor for pancreatic ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 10: S. 1887-1897
Zhao, Yue; Altendorf-Hofmann, Annelore; Pozios, Ioannis; Camaj, Peter; Däberitz, Therese; Wang, Xiaoyan; Niess, Hanno; Seeliger, Hendrik; Popp, Felix; Betzler, Christopher; Settmacher, Utz; Jauch, Karl-Walter; Bruns, Christiane und Knösel, Thomas
(2017):
Elevated interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) is a poor prognostic marker in pancreatic ductal adenocarcinoma.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 6: S. 1061-1068
Gallmeier, Eike; Bader, Dominik C.; Kriegl, Lydia; Berezowska, Sabina; Seeliger, Hendrik; Göke, Burkhard; Kirchner, Thomas; Bruns, Christiane und De Toni, Enrico N.
(2013):
Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.
In: PLOS ONE
8(2), e56760
[PDF, 785kB]
Camaj, Peter; Seeliger, Hendrik; Ischenko, Ivan; Krebs, Stefan; Blum, Helmut; De Toni, Enrico N.; Faktorova, Dagmar; Jauch, Karl-Walter und Bruns, Christiane J.
(2009):
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells.
In: Biological Chemistry, Bd. 390, Nr. 12: S. 1293-1302
[PDF, 218kB]
Diese Liste wurde am
Sat Mar 16 21:57:01 2024 CET
erstellt.